Brain infarction after percutaneous implantation of port-catheter system via the left subclavian artery

British Journal of Radiology

Volumn 75, Issue 898, 2002, Pages 799-804

  Hirota, T ^a   Yamagami, T ^a   Tanaka, O ^a   Iida, S ^a   Kato, T ^a   Nakamura, T ^a   Ishihara, K ^a   Nishimura, T ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; AUTOPSY; BRAIN INFARCTION; DRUG INFUSION; FEMALE; HUMAN; IMPLANTABLE PORT SYSTEM; INCIDENCE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SUBCLAVIAN ARTERY; THROMBUS;

EID: 0036774658     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.75.898.750799     Document Type: Article

References (27)

1. Sterchi JM. Hepatic artery infusion for metastatic neoplastic disease. Surg Gynecol Obstet 1985;160:477-89.
2. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53:1336-43.
3. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasis. Lancet 1994;344:1255-60.
4. Jakob AR, Kühl M, Jauch KW, Schalhorn A, Wilmanns W. Complications using implantable port-systems for regional chemotherapy of liver metastases. Reg Cancer Treat 1996;9:33-6.
5. Laffer U, Dürig M, Bloch HR, Zuber M, Stoll HR. Implantable catheter systems: results in 205 surgical patients. Dtsch Med Wochenschr 1989;114:655-8.
6. Huk I, Entscheff P, Prager M, Schulz F, Polterauer P, Funovics J. Patency rate of implantable devices during long-term, intraarterial chemotherapy. Angiology 1990;41:936-41.
7. Dresing K, Lottner C, Stock W. Duodenal perforation of an intraarterial port catheter and other complications following port implantation for regional cytostatic infusion of the liver. Med Klin 1991;86:245-50.
8. Henne-Bruns D, Marks GH, Marks V, Weh HJ, Kremer B. Intraarterial chemotherapy in the treatment of liver malignancies. Zentralbl Chir 1989;114:668-76.
9. Germer CT, Boese-Landgraf J, Albrecht D, Wagner A, Wolf KJ, Buhr HJ. The totally implantable minimally invasive hepatic artery catheter for intraarterial chemotherapy of unresectable liver metastases in cases of dysfunction of arterial access devices. Chirurg 1996;67:458-62.
10. Wacker FK, Boese-Landgraf J, Albrecht D, Wolf KJ, Fobbe F. Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 1997;20:128-32.
11. Strecker EPK, Boos IBL, Ostheim-Dzerowycz W, Heber R, Vetter SC. Percutaneously implantable catheter-port system: preliminary technical results. Radiology 1997;202:574-7.
12. Arai Y, Inaba Y, Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR, editor. Interventional Radiology (3rd edn). Baltimore, MD: Williams and Wilkins, 1997;192-205.
13. Oi H, Kishimoto H, Matsushita M, Hori M, Nakamura H. Percutaneous implantation of hepatic artery infusion reservoir by sonographically guided left subclavian artery puncture. AJR 1996;166: 821-2.
14. Yamagami T, Nakamura T, Yamazaki T, Iida S, Kato T, Nishimura T. Catheter-tip fixation of a percutaneously implanted port-catheter system to prevent dislocation. Eur Radiol 2002;12:443-9.
15. Yamagami T, Nakamura T, Maeda T. Aberrant gastric venous inflow to the left lobe of the liver parenchyma adjacent to the falciform ligament. Br J Radiol 1999;72:903-5.
16. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 2000;215:294-9.
17. Kuroiwa T, Honda H, Yoshimitsu K, Irie H, Aibe H, Tajima T, et al. Complications encountered with a transfemorally placed port-catheter system for hepatic artery chemotherapy infusion. Cardiovasc Intervent Radiol 2001;24:90-3.
18. Clouse ME, Ahmed R, Ryan RB, Oberfield RA, McCaffrey JA. Complications of long term transbrachial hepatic arterial infusion chemotherapy. AJR 1977;129:799-803.
19. Oberfield RA, McCaffrey JA, Polio J, Clouse ME, Hamilton T. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44:414-23.
20. Takeuchi Y, Arai Y, Inaba Y, et al. A new percutaneous catheterization "side-holed catheter placement with fixation" for a long term arterial chemotherapeutic infusion: its effectiveness to prevent hepatic arterial occlusion. Japan J Intervent Radiol 1996;11:471-6. (In Japanese).
21. Minoyama A, Yoshikawa M, Ebara M, Saisho H, Sugiura N, Ohto M. Study of repeated arterial infusion chemotherapy with a subcutaneously implanted reservoir for advanced hepatocellular carcinoma. J Gastroenterol 1995;30:356-66.
22. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, et al. The efficacy of continuous local arterial infusion of 5-fluorouracil and cisplatin through an implanted reservoir for severe advanced hepatocellular carcinoma. Oncology 1995;52:295-9.
23. Irie T. Intraarterial chemotherapy of liver metastases: implantation of a microcatheter-port system with use of modified fixed catheter tip technique. J Vasc Interv Radiol 2001;12:1215-8.
24. Munemori O, Kajihara Y, Imai S, Kamei T, Mori T, Nishishita S. A case of thrombus on the abdominal aortic wall caused by a heparin-coated catheter. Kawasaki Ikaishi 1992;18:41-6. (In Japanese.)
25. Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 2000;31:2616-22.
26. Luzzatto G, Schafer AI. The prethrombotic state in cancer. Semin Oncol 1990;17:147-59.
27. Patterson WP, Ringenberg QS. The pathophysiology of thrombosis in cancer. Semin Oncol 1990;17:140-6.